IPCA LABORATORIES
Quarterly Results Analysis [Dec2023]
IPCA LABORATORIES Quarterly Results
Consolidated | Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 UnAudited |
Mar2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹2,053 Cr | ₹2,034 Cr | ₹1,588 Cr | ₹1,512 Cr | ₹1,546 Cr | ₹1,601 Cr | ₹1,586 Cr | ₹1,289 Cr |
Expenses | ₹1,722 Cr | ₹1,713 Cr | ₹1,280 Cr | ₹1,331 Cr | ₹1,330 Cr | ₹1,340 Cr | ₹1,317 Cr | ₹1,070 Cr |
Operating Income | ₹331 Cr | ₹321 Cr | ₹308 Cr | ₹181 Cr | ₹216 Cr | ₹261 Cr | ₹269 Cr | ₹219 Cr |
Other Income | ₹22 Cr | ₹39 Cr | ₹45 Cr | ₹36 Cr | ₹31 Cr | ₹36 Cr | ₹22 Cr | ₹15 Cr |
Interest | ₹33 Cr | ₹44 Cr | ₹31 Cr | ₹18 Cr | ₹11 Cr | ₹9 Cr | ₹7 Cr | ₹3 Cr |
Depreciation | ₹100 Cr | ₹90 Cr | ₹69 Cr | ₹70 Cr | ₹67 Cr | ₹64 Cr | ₹62 Cr | ₹61 Cr |
Profit Before Tax | ₹289 Cr | ₹225 Cr | ₹252 Cr | ₹129 Cr | ₹169 Cr | ₹224 Cr | ₹223 Cr | ₹170 Cr |
Profit After Tax | ₹223 Cr | ₹137 Cr | ₹166 Cr | ₹81 Cr | ₹116 Cr | ₹147 Cr | ₹148 Cr | ₹141 Cr |
EPS | ₹7.09 | ₹5.72 | ₹6.42 | ₹3.02 | ₹4.25 | ₹5.67 | ₹5.64 | ₹5.13 |
Industry Peers & Returns | 1W | 1M | 1Y |
IPCA LABORATORIES | 0.7% | 11.8% | 60.8% |
SUN PHARMACEUTICAL INDUSTRIES | -2.3% | -6.5% | 55.3% |
CIPLA | 4.1% | -4.8% | 55.6% |
DR REDDYS LABORATORIES | 4% | 0.8% | 29.4% |
ZYDUS LIFESCIENCES | -1.2% | -5.2% | 83.9% |
DIVIS LABORATORIES | 7.8% | 17.4% | 20.3% |
MANKIND PHARMA | 1.3% | 7% | NA |
TORRENT PHARMACEUTICALS | 3.9% | 5.1% | 66.1% |
LUPIN | 0.6% | 0.5% | 127.2% |
IPCA LABORATORIES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 0.93 % |
Y-o-Y | 32.79 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹2,053 Cr | 0.93 | |
Sep2023 | ₹2,034 Cr | 28.12 | |
Jun2023 | ₹1,588 Cr | 5.02 | |
Mar2023 | ₹1,512 Cr | -2.22 | |
Dec2022 | ₹1,546 Cr | -3.43 | |
Sep2022 | ₹1,601 Cr | 0.96 | |
Jun2022 | ₹1,586 Cr | 23.01 | |
Mar2022 | ₹1,289 Cr | - |
IPCA LABORATORIES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 3.13 % |
Y-o-Y | 53.49 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹331 Cr | 3.13 | |
Sep2023 | ₹321 Cr | 4.44 | |
Jun2023 | ₹308 Cr | 69.92 | |
Mar2023 | ₹181 Cr | -16.13 | |
Dec2022 | ₹216 Cr | -17.18 | |
Sep2022 | ₹261 Cr | -3.19 | |
Jun2022 | ₹269 Cr | 22.75 | |
Mar2022 | ₹219 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 2.15 % |
Y-o-Y | 15.62 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 16.14% | 2.15 | |
Sep2023 | 15.8% | -18.47 | |
Jun2023 | 19.38% | 61.77 | |
Mar2023 | 11.98% | -14.18 | |
Dec2022 | 13.96% | -14.25 | |
Sep2022 | 16.28% | -4.12 | |
Jun2022 | 16.98% | -0.18 | |
Mar2022 | 17.01% | - |
IPCA LABORATORIES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 62.00 % |
Y-o-Y | 92.59 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹223 Cr | 62.00 | |
Sep2023 | ₹137 Cr | -17.31 | |
Jun2023 | ₹166 Cr | 105.02 | |
Mar2023 | ₹81 Cr | -29.88 | |
Dec2022 | ₹116 Cr | -21.26 | |
Sep2022 | ₹147 Cr | -1.08 | |
Jun2022 | ₹148 Cr | 5.43 | |
Mar2022 | ₹141 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 60.50 % |
Y-o-Y | 45.05 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 10.85 % | 60.50 | |
Sep2023 | 6.76 % | -35.43 | |
Jun2023 | 10.47 % | 95.34 | |
Mar2023 | 5.36 % | -28.34 | |
Dec2022 | 7.48 % | -18.43 | |
Sep2022 | 9.17 % | -2.03 | |
Jun2022 | 9.36 % | -14.29 | |
Mar2022 | 10.92 % | - |
IPCA LABORATORIES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 23.95 % |
Y-o-Y | 66.82 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹7.09 | 23.95 | |
Sep2023 | ₹5.72 | -10.90 | |
Jun2023 | ₹6.42 | 112.58 | |
Mar2023 | ₹3.02 | -28.94 | |
Dec2022 | ₹4.25 | -25.04 | |
Sep2022 | ₹5.67 | 0.53 | |
Jun2022 | ₹5.64 | 9.94 | |
Mar2022 | ₹5.13 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD